✦ LIBER ✦

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

✍ Scribed by Alexandra Alexopoulou; Ania M. Owsianka; Georgia Kafiri; Spyros P. Dourakis; William F. Carman; Stephanos J. Hadziyannis

Book ID: 118567856
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 251 KB
Volume: 29
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80050-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained response to the interferon the

Sustained response to the interferon therapy in HBeAg(+) chronic hepatitis B is not sustained

✍ Ulus S. Akarca; Elif Lebe; Fulya Gunsar; Zeki Karasu; Nermin Kilincsoy; Galip Er 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Commentary: HBsAg levels as predictor of

Commentary: HBsAg levels as predictor of sustained response to peg interferon in HBeAg-negative chronic hepatitis B

✍ S. J. Hadziyannis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Occult hepatitis B virus infection does

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C

✍ Paolo Fabris; Dave Brown; Giulia Tositti; Loredana Bozzola; Maria Teresa Giordan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Patterns of viral decline during PEG-int

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

✍ Martijn J. ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

In chronic hepatitis B, it is difficult to predict an early therapeutic response. We investigated the viral decline during therapy with pegylated interferon alpha-2b (PEG-IFN) with or without lamivudine in 266 HBeAg-positive chronic hepatitis B patients. In patients treated with PEG-IFN and lamivudi

Outcome of liver disease and response to

Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis

✍ Filippo Schepis; Gabriella Verucchi; Teresa Pollicino; Luciano Attard; Santa Bra 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Polymorphisms in ADAR1 gene affect respo

Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese

✍ Xiaopan Wu; Zhenhui Xin; Xilin Zhu; Liping Pan; Zhuo Li; Hui Li; Ying Liu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB